Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Recent studies showed that nonnucleoside reverse transcriptase inhibitors (NNRTIs) have variable effects on dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT). Efavirenz, one of three NNRTIs currently used in highly active anti-retroviral therapy, enhances subunit dimerization. Sedimentation equilibrium experiments on each subunit and equimolar mixtures of both subunits were used to measure dissociation constants for the three coupled dimerization reactions of RT in the absence and presence of saturating concentrations of the drug. The dimerization constants of the p51/p51 homodimer, the p66/p66 homodimer, and the p66/p51 heterodimer increased 600-, 50-, and 25-fold, respectively, upon binding of efavirenz. The effects of NNRTIs on RT dimerization are consistent with a thermodynamic linkage between subunit association/dissociation and inhibitor binding. Analysis of crystal structures of the p66/p51 heterodimer reveals that efavirenz binding induces small structural changes at the dimer interface.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, this approach is supported by the observation that a single substitution mutation in RT significantly lowers the dimerization affinity, suggesting that it is possible to reduce dimerization by targeting key contacts in the interface [107,118-121].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [119]
Citations
Cites
Press, W. H., Flannery, B. P., Teukolsky, S. A., & Vetterling, W. T. (2007) · Cited by 796
Rapid Attainment of Sedimentation Equilibrium
Van Holde, K. E., & Baldwin, R. L. (1958) · The Journal of Physical Chemistry · doi:10.1021/j150564a025 · Cited by 763
Restle, T., Müller, B., & Goody, R. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38799-x · Cited by 184
Lindberg, J., Sigurðsson, S., Löwgren, S., Andersson, H. O., Sahlberg, C., Noréen, R., Fridborg, K., Zhang, H., & Unge, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2002.02811.x · Cited by 136
RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms
Restle, T., Müller, B., & Goody, R. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80172-d · Cited by 68
Kensch, O., Restle, T., Wöhrl, B. M., Goody, R. S., & Steinhoff, H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3998 · Cited by 59
Tachedjian, G., Moore, K. L., Goff, S. P., & Sluis‐Cremer, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.099 · Cited by 57
Peletskaya, E. N., Kogon, A. A., Tuske, S. J., Arnold, E., & Hughes, S. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3387-3397.2004 · Cited by 42
Bavand, M. R., Wagner, R., & Richmond, T. J. (1993) · Biochemistry · doi:10.1021/bi00091a003 · Cited by 30
Factors affecting the dimerization of the p66 form of HIV‐1 reverse transcriptase
Cabodevilla, J. F., Odriozola, L., Santiago, E., & Martínez-Irujo, J. J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01939.x · Cited by 26
Research works printed but not linked: 31
- Le Grice S. F. J., 1991, EMBO J., 10
- Becerra S. P., 1991, Biochemistry 30, 11707−11719.
- Divita G., 1995, Biochemistry 34, 16337−16346.
- Lebowitz J., 1994, Protein Sci. 3, 1374−1382.
- Sluis-Cremer N., 2002, Mol. Pharmacol. 62, 398−405.
- Sluis-Cremer N., 2000, Biochemistry 39, 1427−1433.
- Mao C., 2000, Biochem. Pharmacol. 60, 1251−1265.
- Sluis-Cremer N., 2004, Curr. HIV Res. 2, 323−332.
- Borkow G., 1997, Biochemistry 36, 3179−3185.
- Tachedjian G., 2001, Proc. Natl. Acad. Sci. U.S.A. 98
- Merluzzi V. J., 1990, Science 250, 1411−1413.
- Spence R. A., 1995, Science 267, 988−993.
- Kohlstaedt L. A., 1992, Science 256, 1783−1790.
- Ren J., 2000, Structure 8, 1089−1094.
- Le Grice S. F. J., 1995, Methods Enzymol. 262, 130−144.
- Gill S. C., 1989, Anal. Biochem. 182, 319−326.
- Ignatov M. E., 2005, Biochemistry 44, 5346−5356.
- Makhatadze G. I., 1990, Partial molar, 30
- Gekko K., 1981, Biochemistry 20, 4667−4676.
- Osbourne J. C., Jr., 1984, J. Biol. Chem., 259
- Lewis M. S., 2004, Methods Enzymol. 384, 232−242.
- Rodgers D. W., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Hsiou Y., 1996, Structure 4, 853−857.
- Holladay L. A., 1972, J. Biol. Chem., 247
- Rausch J. W., 2000, J. Biol. Chem., 275
- Rothwell P. J., 2003, Proc. Natl. Acad. Sci. U.S.A. 100, 1655−1660.
- Young S. D., 1995, Antimicrob. Agents Chemother. 39, 2602−2605.
- Maga G., 2000, Antimicrob. Agents Chemother. 44, 1186−1194.
- Tachedjian G., 2005, Bioinf., 60, 13
- Wang J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91
- Jacobo-Molina A., 1993, Proc. Natl. Acad. Sci. U.S.A. 90
Cited by
Dynamic binding orientations direct activity of HIV reverse transcriptase
Abbondanzieri, E. A., Bokinsky, G., Rausch, J. W., Zhang, J. X., Le Grice, S. F. J., & Zhuang, X. (2008) · Nature · doi:10.1038/nature06941 · Cited by 186
Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
Sluis-Cremer, N., & Tachedjian, G. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.002 · Cited by 172
Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
Figueiredo, A., Moore, K. L., Mak, J., Sluis‐Cremer, N., de Béthune, M., & Tachedjian, G. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020119 · Cited by 118
Liu, S., Harada, B. T., Miller, J. T., Grice, S. F. J. L., & Zhuang, X. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1937 · Cited by 75
Allosteric Suppression of HIV-1 Reverse Transcriptase Structural Dynamics upon Inhibitor Binding
Seckler, J. M., Barkley, M. D., & Wintrode, P. L. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.11.004 · Cited by 57
Self-citation
Metadata
- Authors
- Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Holladay, Leslie A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-02-10
- Volume
- 45
- Issue
- 9
- Pages
- 2779-2789
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2085882047
- Cited by
- 59
- References
- 12
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm052263-08)
- National Heart, Lung, and Blood Institute (HL07653, T32HL007653)
- National Institute of General Medical Sciences (GM 52263)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- efavirenz, HIV-1 reverse transcriptase, non-nucleoside reverse transcriptase inhibitors, p66/p51 heterodimer, subunit dimerization, inhibitor binding, dissociation constant, antiretroviral therapy
- MeSH terms
- Alkynes, Binding Sites, Cyclopropanes, Kinetics, Oxazines, Protein Conformation, Structure-Activity Relationship, Thermodynamics, Reverse Transcriptase Inhibitors, Dimerization, Protein Subunits, Benzoxazines, HIV Reverse Transcriptase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase. https://app.cochat.ai/papers/10.1021/bi051915z
- The paper
- Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., & Barkley, M. D. (2006). Effects of Efavirenz Binding on the Subunit Equilibria of HIV-1 Reverse Transcriptase. Biochemistry. https://doi.org/10.1021/bi051915z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.